Class Action Launched Over Actos Drug

Toronto class action firm, Rochon Genova, filed a claim earlier today over a diabetes drug.

Actos (pioglitazone) is manufactured by Takeda Pharmaceutical Company, the largest pharmaceutical company in Japan and one of the top 20 pharmaceutical companies in the world.

The lead plaintiff was prescribed Actos for diabetes in 2002, before contracting bladder cancer in 2009 and passing away in April of this year.  A U.S. Food and Drug Administration (FDA) safety alert from August 4, 2011 indicates,

The U.S. Food and Drug Administration (FDA) is informing the public that the Agency has approved updated drug labels for the pioglitazone-containing medicines to include safety information that the use of pioglitazone for more than one year may be associated with an increased risk of bladder cancer.

Omar Ha-Redeye is the Principal of Fleet Street Law, a full-service law chambers in Toronto.